Nicole Grunenberg

9PUBLICATIONS
71CO-AUTHORS
Innate immunityPacific Peoples health promotion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 19, 2024
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.

Zoe Moodie, Erica Andersen-Nissen, Nicole Grunenberg

|Apr 16, 2021
Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans.

Kelly E Seaton, Aaron Deal, Xue Han

|Mar 15, 2021
Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk.

Erica Andersen-Nissen, Andrew Fiore-Gartland, Lamar Ballweber Fleming

|May 23, 2020
Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.

Zoe Moodie, Stephen R Walsh, Fatima Laher

|Feb 25, 2020
Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.

Fatima Laher, Zoe Moodie, Kristen W Cohen

|Feb 09, 2020
HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens.

Xiaoying Shen, Fatima Laher, Zoe Moodie

Pageof 2

Frequent Collaborators

6 joint publications

Fatima Laher

5 joint publications

Peter B Gilbert

5 joint publications

Lawrence Corey

5 joint publications

M Juliana McElrath